|
|
|
||
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
|
(Zip Code)
|
|
(Address of principal executive offices)
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which
registered
|
|
|
|
Item 7.01. |
Regulation FD Disclosure.
|
Item 9.01 |
Financial Statements and Exhibits.
|
Exhibit
No.
|
Description
|
|
Press release issued by Insmed Incorporated on February 19, 2021.
|
||
Insmed Incorporated February 19, 2021 TPIP Topline Data Presentation.
|
||
104
|
Cover Page Interactive Date File (embedded within the Inline XBRL document).
|
INSMED INCORPORATED
|
||
Dated: February 19, 2021
|
By:
|
/s/ Christine Pellizzari
|
Name:
|
Christine Pellizzari
|
|
Title:
|
Chief Legal Officer
|